Since involvement of the PI3K/Akt/MMP-2/9 axis in CRC metastasis has been reported before 43,44, we further investigate the effects of combined treatment using GL-V9 and Akt activator IGF-1 on the expression of MMP-2 and MMP-9. This evidence concerns the gene MMP2 and colorectal carcinoma.